Endoscopic Management of Post-Tracheostomy Tracheal Stenosis: 10-Year Results from a Chinese Interventional Center
Tracheostomy is a life-saving procedure for patients with severe breathing difficulties, but it carries a hidden risk—post-tracheostomy tracheal stenosis (PTTS). This narrowing of the airway affects thousands of people yearly, making breathing labored and reducing quality of life. Until recently, treatment options were limited: open surgery was the gold standard but came with high risks for patients with heart, lung, or brain conditions. Now, a decade-long study from Beijing Tian Tan Hospital offers new hope: minimally invasive endoscopic procedures may be a safer, effective first-line treatment for PTTS.
What Is PTTS—and Why Is It Hard to Treat?
PTTS develops when the tracheostomy tube damages airway cartilage, causes tissue death from reduced blood flow, triggers infection, or rubs against the tracheal wall over time. Unlike post-intubation tracheal stenosis (PITS)—which has become less common with better tube cuffs—PTTS remains widespread. For years, surgeons recommended open resection (cutting out the narrowed section and reattaching the airway), but this approach has a 5–15% failure rate and 5% mortality rate, according to a 2002 study in European Journal of Cardiothoracic Surgery. It’s also off-limits for patients with long stenotic segments (>5 cm) or severe comorbidities.
A 10-Year Look at Endoscopic Treatment
Researchers from the Department of Respiratory Medicine at Beijing Tian Tan Hospital (Capital Medical University) analyzed data from 87 PTTS patients treated between 2009 and 2019. All started with endoscopic procedures—no open surgery first. The team used flexible or rigid bronchoscopes (thin, camera-equipped tubes) to perform:
- Cryotherapy: Freezing scar tissue to slow regrowth (used in 69% of patients).
- Balloon dilation: Inflating a small balloon to widen the airway (39% of patients).
- High-frequency electric knife: Cutting scar tissue rings (36% of patients).
- Local paclitaxel: Applying a drug to reduce scarring (35% of patients).
For patients with “collapsible” airway narrowing (dynamic stenosis), the team inserted Montgomery T-tubes—small devices that keep the airway open while letting patients breathe normally and speak.
Who Was Studied?
The 87 patients averaged 48 years old, with 65% male. Over 40% had been intubated before their tracheostomy. The team classified stenosis by location:
- Type 1: Upper end of the tracheostomy site (32 patients).
- Type 2: Around the tracheostomy site (34 patients).
- Type 3: Lower end of the tracheostomy site (21 patients).
Key Results: Where Endoscopy Shone
Type 2 patients (around the tracheostomy site) had the best outcomes:
- Their stenosis was shortest (1 cm on average, vs. 1.6 cm for Type 1 and 2 cm for Type 3).
- 73.5% achieved decannulation—permanently removing the tracheostomy tube and breathing on their own.
Overall, 47% of patients (41 total) gained long-term airway stability. Only 1 patient died during a procedure (while removing a metal stent from another hospital), and 2 needed surgery after endoscopy failed.
What Predicted Success?
Two factors strongly linked to positive outcomes:
- Local paclitaxel use: Patients who got the drug were 3.7 times more likely to succeed. A 2016 study in Journal of Huazhong University of Science and Technology (Medical Sciences) found paclitaxel slows scar growth in benign airway stenosis.
- Consciousness: Alert patients were 2.6 times more likely to do well—likely because they could follow breathing instructions during treatment.
Why Endoscopy Is a Game-Changer
Endoscopic treatment is safer for patients with severe comorbidities (e.g., heart failure, COPD) who can’t tolerate surgery. For Type 1 stenosis (upper trachea), Montgomery T-tubes were life-changing: 18 patients used them, regaining the ability to breathe naturally and speak. While T-tubes sometimes cause extra tissue growth (granulation) around the edges, regular endoscopic checks fixed this issue.
What This Means for PTTS Patients
The study confirms endoscopic treatment should be the first-line option for PTTS. It’s less invasive, has fewer risks, and works for most people—even those who can’t have surgery. Type 2 stenosis (around the tracheostomy site) has the highest success rate, but all patients can benefit:
- For mild stenosis: Cryotherapy or balloon dilation may be enough.
- For severe narrowing: T-tubes or stents can restore breathing.
The Bottom Line
“Endoscopic treatment lets us fix the airway without big incisions,” says lead researcher Dr. Jie Zhang. “It’s a safer path for PTTS patients, especially those with other health problems. Our 10-year data shows it works—and works well.”
The study “Efficacy and outcomes of endoscopic management of post-tracheostomy tracheal stenosis: a retrospective study from an interventional center in China” was published in the Chinese Medical Journal (2022;135(7):851–853) by Feng Chen, Jie Zhang, Xiaojian Qiu, Ting Wang, and Yinghua Pei from the Department of Respiratory Medicine, Beijing Tian Tan Hospital, Capital Medical University.
doi.org/10.1097/CM9.0000000000001634
Was this helpful?
0 / 0